The dynamics of the Philips Respironics recall (WSJ: Roland, D, 8/17/21) requires all sleep physicians to consider non-CPAP therapies for patients diagnosed with Obstructive Sleep Apnea (OSA). The timeline for Philips to rectify their situation due to foam degradation and its consequences is unknown. Currently, ResMed PAP related devices are on backlog. Additionally, many of the 3 million patients affected by this recall may be reluctant to try CPAP again or simply prefer alternative treatment.
The opioid epidemic in the United States has claimed the lives of over 500,000 people since 2000. But for those who depend on opioid use for long-term pain management, there is a new call for alarm. Recent research shows a concerning connection between opioid use and a variety of sleep-related breathing disorders, including obstructive sleep apnea.
Understanding the link between obstructive sleep apnea and Alzheimer’s disease begins with understanding the role sleep plays in our cognitive health. Years of studies have confirmed that the brain, once thought to be passive during sleep, is actually very active and dependent on sleep to carry out important functions. Comparing the characteristics of obstructive sleep apnea and Alzheimer’s disease and their connection to impaired sleep further substantiates what researchers are continuing to discover; that there is a definite correlation between these diseases.
Recently, Bill of the Month, a crowdsourced investigation of noteworthy medical bills, featured the story of Jose Mendoza, a 61-year-old truck driver who suffered from high blood pressure and obstructive sleep apnea. Mr. Mendoza was diagnosed with OSA 15 years earlier and prescribed a continuous positive airway (CPAP) device to help with his condition. But after about a month, Mr. Mendoza stopped using his equipment because he found it noisy and uncomfortable.
The escalating prevalence of sleep-related conditions such as sleep apnea, with its severe co-morbidities, has elevated sleep medicine to greater significance as an emergent medical practice area. BetterNight offers a complimentary end-to-end sleep care management solution that alleviates the financial and operational burden, helping health systems reach their business goals.
The American Association of Sleep Medicine estimates that untreated sleep apnea costs $30 billion annually in increased healthcare utilization and medical costs associated with these comorbidities. Treating Obstructive Sleep Apnea not only improves health but also reduces the economic burden put on our healthcare system.
It is estimated that over 900 million people worldwide suffer from Obstructive Sleep Apnea, more than 10 times the previous estimate, according to data presented by ResMed. Often overlooked is that Obstructive Sleep Apnea has chronic comorbidities, including cardiovascular disease, diabetes, and hypertension.
HCAP Partners, a California-based private equity firm and nationally recognized impact investor, today announced its series B investment in BetterNight, one of the nation's leading comprehensive virtual-care sleep health solutions.
The trucking industry plays a critical role in the US economy, providing a vital link between manufacturers and consumers. According to the American Trucking Association (ATA), there are approximately 3.6 million professional truck drivers in the United States, making driving a truck one of the nation's largest occupations.
Heart disease is the leading cause of death in the United States, and the latest statistics are quite sobering. According to The Centers for Disease Control and Prevention, one person dies every 36 seconds from cardiovascular disease.
Artificial Intelligence (AI) is one of the most prevalent and transformative technologies available today. In addition to its visibility in the tech sector, AI has been strategically integrated across businesses as diverse as Netflix, Spotify, The New Yorker Magazine and the BBC World News.
Patients who suffer from sleep disorders such as sleep apnea and insomnia are more likely to suffer from other chronic diseases, including diabetes, cardiovascular disease, hypertension, obesity, and depression.
Daylight Saving Time will be ending on November 1, 2020, at 2:00 a.m., at which point we will turn our clocks back one hour. While this is often referred to as “falling back,” the idea that you are “gaining” an hour of sleep is really a fallacy.
By integrated home sleep testing and apnea care management Sharp Community Medical Group (SCMG) has reduced high-cost utilization by over 90% during the past decade. Learn how your ACO can find meaningful savings by integrating a virtual sleep management program.
In this On-Demand BetterNight & EnsoData webinar, we dive into that question, as technology is making waves in more than just diagnosis and treatment. Learn how game-changing AI technology can be predictive of future CPAP problems.
The practice of sleep medicine has been integrating more virtual care for the past few years. The pandemic has only increased the velocity of this change. BetterNight helps sleep physicians, physicians in other specialties, and dentists expand their practices, improve patient outcomes, and integrate virtual care.
By integrated home sleep testing and apnea care management Sharp Community Medical Group (SCMG) has reduced high-cost utilization by over 90% during the past decade. Learn how your ACO can find meaningful savings by integrating a virtual sleep management program.
Along with a healthy diet and exercise, consistent restful sleep is considered the third pillar of good health. The link between sleep deprivation and various chronic physical illnesses, including heart disease, obesity, diabetes, hypertension, and cancer, has been well-researched and documented.
